Implantable Cardioverter Defibrillator (ICD Registry)

Launched by AMERICAN COLLEGE OF CARDIOLOGY · Nov 26, 2013

Keywords

ClinConnect Summary

The ICD Registry is a nationwide program aimed at improving the care of patients who receive implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy devices with defibrillators (CRT-Ds). These devices are important for patients with heart problems, as they help prevent dangerous heart rhythms that can lead to serious complications. The registry collects information about patients, their treatments, and their outcomes, allowing hospitals to measure how well they are taking care of these patients and learn from the data.

Anyone who receives an ICD or CRT-D, whether it's their first device or a replacement, may be eligible to participate in this trial. This includes patients in the U.S. and internationally, even if they have had a specific procedure involving just the leads of the device. Participants can expect their information to be tracked to help hospitals improve care for future patients. Importantly, there are no exclusions based on patient characteristics, ensuring that a broad range of individuals can contribute to this important research.

Gender

ALL

Eligibility criteria

• • All U.S and International patients.
• Inclusion Criteria:
• • All patients who receive an ICD/CRT-D (initial or generator change) for primary or secondary prevention purposes.
• • All patients with an ICD/CRT-D undergoing a Lead Only procedure.
• • U.S. populations must submit all patients who receive an ICD/CRT-D (initial or generator change) for primary prevention purposes who are insured by Medicare.
• Exclusion Criteria:
• • None